Affinity Asset Advisors »

Kezar Life Sciences shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Kezar Life Sciences (KZR) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Kezar Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Kezar Life Sciences held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kezar Life Sciences by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.6M 1.8M 0.90

More positions owned by Affinity Asset Advisors

Spdr Ser Tr S&p Biotech Put Option (XBI)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Moderna Put Option (MRNA)
Apogee Therapeutics (APGE)
Xenon Pharmaceuticals (XENE)
Madrigal Pharmaceuticals (MDGL)
Crinetics Pharmaceuticals In (CRNX)
Autolus Therapeutics Spon Ads (AUTL)
Celldex Therapeutics Com New (CLDX)
Arcellx Common Stock (ACLX)
Vera Therapeutics Cl A (VERA)
Inozyme Pharma (INZY)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Kura Oncology (KURA)
Spyre Therapeutics Com New (SYRE)

View all positions for Affinity Asset Advisors

Top funds holding Kezar Life Sciences

Suvretta Capital Management
Avidity Partners Management
BlackRock
Vanguard Group
Sphera Funds Management
OrbiMed Advisors
Acadian Asset Management
Affinity Asset Advisors
Geode Capital Management
Renaissance Technologies
Two Sigma Investments
Two Sigma Advisers
State Street Corporation
Prosight Management
Ikarian Capital

View all funds holding Kezar Life Sciences